EK, M., S, H., K, M., AM, P., C, S., KC, W., . . . N, W. (2023). Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal, 13(1), 1. https://doi.org/10.1038/s41408-022-00772-9
Chicago Style (17th ed.) CitationEK, Mai, et al. "Implications and Prognostic Impact of Mass Spectrometry in Patients with Newly-diagnosed Multiple Myeloma." Blood Cancer Journal 13, no. 1 (2023): 1. https://doi.org/10.1038/s41408-022-00772-9.
MLA (9th ed.) CitationEK, Mai, et al. "Implications and Prognostic Impact of Mass Spectrometry in Patients with Newly-diagnosed Multiple Myeloma." Blood Cancer Journal, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41408-022-00772-9.
Warning: These citations may not always be 100% accurate.